February 26, 2020 by Chain Drug Review
Alliance for Pharmacy Compounding, American Pharmacists Association, American Society of Consultant Pharmacists, National Alliance of State Pharmacy Associations, National Community Pharmacists Association
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The Alliance for Pharmacy Compounding, American Pharmacists Association, American Society of Consultant Pharmacists, National Alliance of State Pharmacy Associations, and National Community Pharmacists Association collectively urged “reinvigorated and reimagined antitrust enforcement policy” in joint comments submitted Wednesday to the Federal Trade Commission and the Department of Justice Antitrust Division. Earlier this year,
February 18, 2020 by Chain Drug Review
B. Douglas Hoey, FTC and DOJ issued draft guidelines on vertical mergers in the health care industry., National Community Pharmacists Association
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The surge in vertical integration in the health care industry has created “an oligopoly of integrated health care companies controlling nearly all aspects of the health care and pharmacy supply chain,” said the National Community Pharmacists Association in comments submitted Tuesday to the Federal Trade Commission and the U.S. Department of Justice
February 12, 2020 by Chain Drug Review
B. Douglas Hoey, National Community Pharmacists Association, National Community Pharmacists Association during NCPA’s recent annual convention in Boston, XIL Consulting
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – A new report by one of the country’s top pharmacy industry analysts shows how giant corporate middlemen are using “obscure” fees to scoop up billions in additional profits at the expense of patients and their neighborhood pharmacies, said the National Community Pharmacists Association on Wednesday. “It should be shocking to state and
January 30, 2020 by Chain Drug Review
Florida Pharmacy Association and American Pharmacy Cooperative, National Community Pharmacists Association, NCPA CEO B. Douglas Hoey
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — A report released Thursday by the Florida Pharmacy Association and American Pharmacy Cooperative, paints a vivid picture of how pharmacy benefit managers and Medicaid managed care organizations are pushing prescriptions and taxpayer dollars to pharmacies they own or control. The ultimate results, says the National Community Pharmacists Association, are higher costs, fewer choices for patients, and a growing number of neighborhood
January 21, 2020 by Chain Drug Review
Centers for Medicare & Medicaid Services, National Community Pharmacists Association, NCPA, Ronna Hauser
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — In comments to the Centers for Medicare & Medicaid Services, the National Community Pharmacists Association urged the agency to enhance coverage of pharmacist-provided care services and reevaluate strict supervision requirements as well as coverage policies for incident-to services. In response to President Trump’s Executive Order #13890 on Protecting and Improving Medicare for
December 16, 2019 by Chain Drug Review
National Community Pharmacists Association, Ronna Hauser
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Ronna Hauser, vice president of policy and government affairs operations at the National Community Pharmacists Association, will be testifying at the Senate Judiciary Committee’s hearing on Tuesday titled, “Tackling the Opioid Crisis: A Whole-of-Government Approach.” The hearing will look at the implementation of two pieces of legislation targeting the opioid crisis, the
October 31, 2019 by Chain Drug Review
B. Douglas Hoey, National Community Pharmacists Association, NCPA, Seniors would have more convenient access to discounted or “preferred” copays for prescription drugs at their pharmacy of choice under legislatio
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Seniors would have more convenient access to discounted or “preferred” copays for prescription drugs at their pharmacy of choice under legislation reintroduced Thursday by Reps. Peter Welch (D, Vt.) and Morgan Griffith (R, Va.). The bipartisan legislation is endorsed by the National Community Pharmacists Association. NCPA chief executive officer B. Douglas Hoey
October 30, 2019 by Chain Drug Review
National Community Pharmacists Association, NCPA’s House of Delegates, Pharmacist Brian Caswell of Wolkar Drug, urging policymakers to support reforms compensating pharmacists for the true cost of dispensing medicines
Leading Headlines, Pharmacy
SAN DIEGO – Pharmacist Brian Caswell of Wolkar Drug in Baxter Springs, Kan. was installed as the 2019-2020 president of the National Community Pharmacists Association on Tuesday at the organization’s Annual Convention. “Both changing the payment model and pharmacy practice transformation are futuristic goals unimaginable even just a few years ago,” said Caswell. “NCPA strongly
July 26, 2019 by Chain Drug Review
direct and indirect remuneration (DIR) fee reform, Drug Pricing Reduction Act (PDPRA) of 2019, Iowa), NACDS, National Association of Chain Drug Stores, National Association of Specialty Pharmacy, National Community Pharmacists Association, Senate Finance Committee chairman Chuck Grassley (R
Featured Articles, Leading Headlines, Pharmacy
WASHINGTON – With the Senate Finance Committee holding a legislative markup today of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, eight associations noted initial bipartisan movement on direct and indirect remuneration (DIR) fee reform, but reiterated the need for swift and decisive action on this issue. Issuing a joint statement were: National Community
July 23, 2019 by Chain Drug Review
B. Douglas Hoey, DIR fees, National Community Pharmacists Association, PBMs
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — In print ads Tuesday in the Washington Post and the Wall Street Journal, the National Community Pharmacists Association is urging policymakers to rein in pharmacy benefit managers to help lower drug costs. These ads complement NCPA’s ongoing efforts in its years-long campaign to reform pharmacy direct and indirect remuneration (DIR) fees, a
July 11, 2019 by Chain Drug Review
National Community Pharmacists Association, pharmacy DIR fee reform
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — Support for pharmacy direct and indirect remuneration fee reform continues to grow, with 204 pharmacy stakeholder and patient advocacy groups urging the Senate Finance Committee to include pharmacy DIR fee reform in its forthcoming drug pricing legislation. Nearly a quarter of the U.S. House of Representatives and more than a quarter of
June 26, 2019 by Chain Drug Review
Fix DIR Day, National Community Pharmacists Association, NCPA chief executive officer B. Douglas Hoey
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association and its 22,000 member pharmacies are launching Fix DIR Day on Thursday, June 27. Pharmacy stakeholders will be mobilizing their legislators in Congress to contact members of the Senate Finance Committee and urge them to address pharmacy direct and indirect remuneration fees, or pharmacy DIR, in their
March 13, 2019 by Chain Drug Review
B. Douglas Hoey, National Community Pharmacists Association, West Virginia Medicaid agency
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — When the West Virginia Medicaid agency started managing the Medicaid managed care prescription drug benefit directly in July 2017, state officials were relying on an actuarial study forecasting a $30 million savings for the state. This week, the West Virginia Bureau for Medical Services released a report showing actual savings of $54.4
February 7, 2019 by Chain Drug Review
B. Douglas Hoey, Chateau Drugs and Gifts, Kerry and Diane Milano, National Community Pharmacists Association, U.S. Department of Health and Human Services Secretary Alex Azar
Featured Articles, Leading Headlines, Pharmacy
METAIRIE, La. — U.S. Department of Health and Human Services Secretary Alex Azar yesterday visited Chateau Drugs and Gifts in Metairie, La., which is owned by National Community Pharmacists Association (NCPA) members Kerry and Diane Milano, both of whom are registered pharmacists. Azar made the visit to help highlight efforts by the Trump administration to
